Negative alactic base excess is reversed by hemoperfusion in septic patients
نویسندگان
چکیده
Introduction: Gattinoni et al. have recently introduced a new parameter: the “alactic base excess” (ABE). ABE is equivalent to number of strong acids, other than lactate, which are present in plasma abnormal concentrations, negative being associated with higher mortality sepsis. Hemoperfusion (HPF) an extracorporeal procedure that involves passage blood through adsorption cartridge, where solutes removed by direct binding sorbent material. Then, it was decided explore influence HPF on value Materials and methods: Basal values ABE, standard excess (SBE), lactate (mean, deviation [SD]) were obtained. The difference between these parameter before after four sessions (HA330) (delta value) evaluated. Student’s t-test Wilcoxon test applied. Results: From 32 patients (age: 57±13) suffering from respiratory insufficiency secondary COVID-19 who treated critical care unit Clinica de la Mujer, Bogotá (Colombia), 6 presented metabolic acidosis (‒2.7±1) SBE (‒4.7±1) high serum (2±0.7 mmol/L). Delta SBE, were: 7.7 (p = 0.005), 6.1 0.003), 1.6 NS), respectively. Thus, significantly reversed HPF, since turned positive without significant change lactate. Conclusion: Negative alactic septic patients. It necessary carry out evaluations larger groups estimate their impact clinical outcomes.
منابع مشابه
Partitioning evolutive standard base excess determinants in septic shock patients.
BACKGROUND AND OBJECTIVES The amount of metabolic acidosis measured through the standard base excess (SBE) has been shown to be an outcome marker and its improvement has been associated with better survival. We studied the mechanism of standard base excess variation in the first three days of intensive care unit (ICU) stay through the evaluation of independent variables of physico-chemical appr...
متن کاملEfficacy of polymyxin B-immobilized fiber hemoperfusion for patients with septic shock caused by Gram-negative bacillus infection
Septic shock-associated mortality in intensive care units (ICUs) remains high, with reported rates ranging 30-50%. In particular, Gram-negative bacilli (GNB), which induce significant inflammation and consequent multiple organ failure, are the etiological bacterial agent in 40% of severe sepsis cases. Hemoperfusion using polymyxin B-immobilized fiber (PMX), which adsorbs endotoxin, is expected ...
متن کاملPolymyxin-B hemoperfusion in septic patients: analysis of a multicenter registry
BACKGROUND In 2010, the EUPHAS 2 collaborative group created a registry with the purpose of recording data from critically ill patients suffering from severe sepsis and septic shock treated with polymyxin-B hemoperfusion (PMX-HP) for endotoxin removal. The aim of the registry was to verify the application of PMX-HP in the daily clinical practice. METHODS The EUPHAS 2 registry involved 57 cent...
متن کاملTime to initiation of treatment with polymyxin B cartridge hemoperfusion in septic shock patients.
BACKGROUND We investigated whether early initiation of hemoperfusion with a polymyxin B cartridge (PMX) after the diagnosis of septic shock could improve the clinical outcome. METHODS A prospective, open-labeled, multicenter cohort study was performed at intensive care units in Japan. 41 patients received PMX within 6 h after the diagnosis of septic shock (early group) and 51 patients were tr...
متن کاملThe effect of endotoxin adsorber hemoperfusion on microcirculation in patients with severe sepsis and septic shock
Introduction Microcirculatory dysfunction may result in multiple organ dysfunction during severe sepsis and septic shock. (1) A meta-analysis of randomized trials showed that polymyxin B hemoperfusion (PMX-HP), plasma exchange, and hemofiltration were associated with lower mortality. (2) Mesenteric microcirculation was better maintained with polymyxin B hemoperfusion in one rat sepsis study. (3...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Giornale di clinica nefrologica e dialisi
سال: 2022
ISSN: ['2705-0076']
DOI: https://doi.org/10.33393/gcnd.2022.2490